Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Controversy surrounding the cholesterol-fighting drug Vytorin continues to escalate as federal and state prosecutors investigate Merck and Schering-Plough’s marketing of the drug. According to an article in the Wall Street Journal, many government officials suspect that the companies’ marketing of Vytorin was misleading and improper.

Read the rest of this entry »